Osaka, Japan

Keisuke Miyajima


 

Average Co-Inventor Count = 9.7

ph-index = 4

Forward Citations = 69(Granted Patents)


Location History:

  • Shiga, JP (1995 - 1997)
  • Otsu, JP (1995 - 2012)
  • Osaka, JP (2013 - 2014)

Company Filing History:


Years Active: 1995-2014

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Keisuke Miyajima: Innovator in Anticancer Compounds

Introduction

Keisuke Miyajima is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer compounds. With a total of 9 patents to his name, Miyajima's work is recognized for its innovative approach to cancer treatment.

Latest Patents

Miyajima's latest patents include groundbreaking inventions such as "Di-substituted pyridine derivatives as anticancers." This invention presents a novel compound that exhibits an excellent antitumor effect. The compound is represented by a specific general formula, where various components are defined to enhance its efficacy. Another notable patent is for a "Heterocyclic compound and pharmaceutical composition thereof," which also follows a defined general formula, showcasing his expertise in creating effective pharmaceutical solutions.

Career Highlights

Throughout his career, Keisuke Miyajima has been associated with Otsuka Pharmaceutical Company, Limited. His work at this esteemed organization has allowed him to focus on research and development in the pharmaceutical sector, contributing to advancements in cancer treatment.

Collaborations

Miyajima has collaborated with notable colleagues such as Satoshi Yamada and Koichi Yasumura. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.

Conclusion

Keisuke Miyajima's contributions to the pharmaceutical industry, particularly in anticancer research, highlight his role as a leading inventor. His innovative patents and collaborations continue to pave the way for advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…